Pethidine Analgesia on Labor Duration

• Status: Completed
• Trial end date: 2018-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

Although opioid analgesics are used to treat labor pain, there are still concerns about their side effects.

The researchers in this study; aimed to evaluate the effect of pethidine on active phase duration of labor, labor pain and maternal-neonatal.

50 mg pethidine will be administered intramuscularly to the cases to be included in the study group. The patients in the control group will be given placebo injections.

Vital signs of all cases included in the study will be checked at 0, 5, 15, 30, 45 and 60 minutes. Pain will also be assessed by Visual Analogue Scale (VAS) before injection and at the 1st and 2nd hour after injection. Delivery times, maternal side effects, neonatal apgar scores and fetal findings will be recorded.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kanuni Sultan Suleyman Training and Research Hospital
• Collaborators: Gaziosmanpasa Research and Education Hospital; Gaziosmanpasa Taksim Research and Education Hospital
• Treatments: Meperidine

Criteria

Inclusion Criteria:

• nullipar-multiparous patients;

• singleton pregnancies 37- 41 weeks (by the last menstrual period).

Exclusion Criteria:

• maternal respiratory rate < 8 /min,

• maternal bradycardia (<60 bpm),

• major fetal congenital anomalies,

• uterine scar presence from previous pregnancies,

• malpresentation,

• antepartum hemorrhage,

• multiple pregnancy,

• labor induction,

• chronic systemic disease,

• rupture fetal membranes,

• epidural analgesia.